Aronne LJ - Search Results

1

Pharmacological management of obesity: an endocrine Society clinical practice guideline.

Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD; Endocrine Society. Apovian CM, et al. Among authors: aronne lj. J Clin Endocrinol Metab. 2015 Feb;100(2):342-62. doi: 10.1210/jc.2014-3415. Epub 2015 Jan 15. J Clin Endocrinol Metab. 2015. PMID: 25590212

2

Obesity.

Aronne LJ. Aronne LJ. Med Clin North Am. 1998 Jan;82(1):161-81. doi: 10.1016/s0025-7125(05)70599-x. Med Clin North Am. 1998. PMID: 9457156 Review.

3

Therapeutic controversy: Obesity--a modern-day epidemic.

Pi-Sunyer FX, Laferrère B, Aronne LJ, Bray GA. Pi-Sunyer FX, et al. Among authors: aronne lj. J Clin Endocrinol Metab. 1999 Jan;84(1):3-12. doi: 10.1210/jcem.84.1.5392-1. J Clin Endocrinol Metab. 1999. PMID: 9920054

4

Pharmacological approaches to weight reduction: therapeutic targets.

Korner J, Aronne LJ. Korner J, et al. Among authors: aronne lj. J Clin Endocrinol Metab. 2004 Jun;89(6):2616-21. doi: 10.1210/jc.2004-0341. J Clin Endocrinol Metab. 2004. PMID: 15181032 Review. No abstract available.

5

Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.

Aronne L, Fujioka K, Aroda V, Chen K, Halseth A, Kesty NC, Burns C, Lush CW, Weyer C. Aronne L, et al. J Clin Endocrinol Metab. 2007 Aug;92(8):2977-83. doi: 10.1210/jc.2006-2003. Epub 2007 May 15. J Clin Endocrinol Metab. 2007. PMID: 17504894 Clinical Trial.

6

Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.

Early JL, Apovian CM, Aronne LJ, Fernstrom MH, Frank A, Greenway FL, Heber D, Kushner RF, Cwik KM, Walch JK, Hewkin AC, Blakesley V. Early JL, et al. Among authors: aronne lj. Obesity (Silver Spring). 2007 Jun;15(6):1464-72. doi: 10.1038/oby.2007.175. Obesity (Silver Spring). 2007. PMID: 17557984 Free article. Clinical Trial.

7

The endocannabinoid system as a target for obesity treatment.

Aronne LJ, Pagotto U, Foster GD, Davis SN. Aronne LJ, et al. Clin Cornerstone. 2008;9(1):52-64; discussion 65-6. doi: 10.1016/s1098-3597(08)60028-9. Clin Cornerstone. 2008. PMID: 19046740

8

New drug targets for the treatment of obesity.

Powell AG, Apovian CM, Aronne LJ. Powell AG, et al. Among authors: aronne lj. Clin Pharmacol Ther. 2011 Jul;90(1):40-51. doi: 10.1038/clpt.2011.82. Epub 2011 Jun 8. Clin Pharmacol Ther. 2011. PMID: 21654742 Review.

9

Emerging pharmacotherapy for obesity.

Aronne LJ, Powell AG, Apovian CM. Aronne LJ, et al. Expert Opin Emerg Drugs. 2011 Sep;16(3):587-96. doi: 10.1517/14728214.2011.609168. Epub 2011 Aug 12. Expert Opin Emerg Drugs. 2011. PMID: 21834735 Review.

10

The combination of phentermine and topiramate is an effective adjunct to diet and lifestyle modification for weight loss and measures of comorbidity in overweight or obese adults with additional metabolic risk factors.

Powell AG, Apovian CM, Aronne LJ. Powell AG, et al. Among authors: aronne lj. Evid Based Med. 2012 Feb;17(1):14-5. doi: 10.1136/ebm.2011.100103. Epub 2011 Sep 21. Evid Based Med. 2012. PMID: 21937501 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page